DENEB MEDICAL, SL

Their core work

Deneb Medical is a Spanish medical device SME based in San Sebastián specialising in computer-assisted surgical robotics for spinal procedures. Their core technology is a smart bone-ablation system — a tool that can selectively cut or remove bony tissue with precision guidance, reducing collateral damage during surgery. They evolved this from a proof-of-concept instrument (BoneCut) into a fully robotic, endoscope-mounted system that uses computer vision to navigate safely during spine operations (X-BONECUT). Their value proposition sits at the intersection of robotics, medical imaging, and minimally invasive surgery.

What they specialise in

How they've shifted over time

Deneb Medical followed a textbook SME instrument progression: a Phase 1 feasibility study (BoneCut, 2018) validated the core idea of computer-guided selective bone ablation, then a Phase 2 full innovation project (X-BONECUT, 2019–2022) scaled it into a commercially viable robotic surgery platform. The shift from "smart ablation tool" to "robotic vision-based endoscopic spine system" shows a deliberate move up the value chain — from a component-level device toward a complete surgical workflow solution. There is no earlier H2020 history to contrast against, but within their short participation window the technology complexity and clinical specificity increased substantially.

Deneb Medical is heading toward a complete robotic spine surgery platform — their trajectory points to commercialisation of X-BONECUT technology and likely expansion into adjacent minimally invasive orthopaedic procedures.

How they like to work

Deneb Medical has used the SME Instrument exclusively, which is a solo-company funding path — both of their projects were self-led with no registered consortium partners. This means they operate as a self-contained innovation unit rather than as a collaborative network node. Anyone considering working with them would likely be engaging as a clinical validation partner, technology integrator, or commercial distributor, not as a co-developer in a traditional multi-partner consortium.

No consortium partners are recorded across their two projects, which reflects the structure of the SME Instrument funding path they used. Their external collaboration footprint within H2020 is effectively zero, making it difficult to assess their broader professional network from this data alone.

What sets them apart

Deneb Medical is one of the few Spanish SMEs that has successfully completed both phases of the SME Instrument in the surgical robotics space, demonstrating execution capability from concept to a multi-million-euro development project. Their specific focus on endoscopic spine surgery — a high-difficulty, high-value surgical domain — positions them in a narrow but commercially important niche where robotic assistance is still far from standard of care. For a consortium needing a medical device developer with hands-on robotic surgical tool expertise and a proven EU funding track record, they are a credible and well-validated partner.

Highlights from their portfolio

• X-BONECUT
  The flagship project: €2.1M Phase 2 SME Instrument grant to develop a full robotic, vision-guided endoscopic spine surgery system — one of the higher-value single-company medical device grants in the H2020 programme.
• BoneCut
  The Phase 1 feasibility study that validated the core bone-ablation concept and directly unlocked the Phase 2 funding, showing a clean technology development pathway.